ELIZABETH SKINNER: Open Payments
NPI 1861880221 · KUTTAWA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 34 payments from 13 companies in 2025. Trend: 2023 $559 · 2024 $747 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $174 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| REVANCE THERAPEUTICS, INC. | 1 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Dexcom, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: LEQVIO, DAXXIFY, Kerendia, OTEZLA, VOQUEZNA, Wegovy, Dexcom G6 Transmitter, PAXLOVID.
Industry payments across KY — which companies pay providers there.
